Ledger.Open graph →

SEC Form D · Amendment · filed August 2, 2010

SYNAGEVA BIOPHARMA CORP

Offering

$45.0M

Sold

$45.0M

Exemption

—

Industry

Biotechnology

Location

WALTHAM, MA

Type

—

People & firms on this filing (14)

Stephen Biggar · Waltham, MADirector Sanj K. Patel · Waltham, MAExec · Director Mark Goldberg · Waltham, MADirector Thomas Malley · Waltham, MADirector Felix Baker · Waltham, MADirector Robyn Samuels · Waltham, MADirector James Rogers · San Mateo, CAExec · Director Lou Salfi · San Mateo, CADirector Christofer Schneider · San Mateo, CADirector Jaap Langenberg · Aptos, CADirector Timothy Redmond · Aptos, CADirector Mark A. Retzloff · Boulder, CODirector Srini Akkaraju · Waltham, MADirector James Tullis · Saddle Brook, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗

SYNAGEVA BIOPHARMA CORP. — SEC Form D filing (2010) | Ledger